WAKEFIELD, Mass., Dec. 9, 2021 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today launched Select X Bites, one of the first edibles on the market designed to have a faster onset while lasting longer with a stronger effect, all made possible by optimizing the absorption and delivery of THC molecules. Select X Bites debuted at Hall of Flowers today and will soon be available in Arizona, Maine, Colorado and Nevada, with other states to follow early next year.
Select’s latest offering invites courageous and experienced cannabis users to a new frontier. Made for the “seasoned explorers” out there, this formula features Select’s award-winning oil and introduces a proprietary encapsulation technology that mimics the body’s natural lipid barrier which optimizes the absorption of THC into the body at a steady, prolonged rate, resulting in a stronger and longer high. Each serving size of Select X Bites contains 10mg of THC, and will first be available in a creamy vanilla-orange flavor called Orange Matter. In the coming months, Select expects to introduce additional “out of this world” flavors.
“Over the past year, Select has introduced a number of new offerings that are not only satisfying unique consumer preferences but also pushing the envelope in terms of what is possible in cannabis, and we are exceptionally proud to introduce one of the most sophisticated edible products in the industry through Select X Bites,” said Joe Bayern, CEO of Curaleaf. “Select was one of the early pioneers of nano-emulsion technology in cannabis which made edibles more predictable – now we are raising the bar and offering customers the opportunity to enjoy more potent edible experiences without compromising the speed or duration of the onset time.”
Select has been working to diversify its edible offerings to ensure there are a variety of reliable options for all cannabis consumers. The portfolio currently includes four varieties of bites:
- Select Bites – A traditional edible experience made with 11 Hydroxy THC which provides a 60-90 minute onset time and long-lasting effects. Available in three flavors including Passion Fruit (Sativa), Blueberry (Indica) and Strawberry Peach (Hybrid).
- Select Nano Bites – The edible, re-invented. Formulated with unique water-soluble Delta 9 THC cannabinoids, users can expect 15-30 minute onset time with mellow, more consistent effects. Flavors include Tangerine (Sativa), Peach Mango (Hybrid) and Pomegranate (Indica).
- Select Snooze Bites – Designed for the perfect wind-down, these delicious blackberry-flavored bites combine a unique 1:1 ratio of fast-acting THC and long-lasting CBN.
- Select X Bites – Made for the more seasoned cannabis users, these bites were created to deliver the fastest, strongest and longest lasting effects of all.
Following its initial launch in Arizona, Maine, Colorado and Nevada, Select X Bites are expected to expand to additional states including Massachusetts, Michigan, California and Maryland. For more information on product availability, please visit https://selectcannabis.com/find-us.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 23 states with 113 dispensaries, 22 cultivation sites and over 30 processing sites, and employs more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the commercialization of Select X Bites. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed April 28, 2021, which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Curaleaf Holdings, Inc.
Carlos Madrazo, SVP Head of IR & Capital Markets
Curaleaf Holdings, Inc.
Tracy Brady, VP Corporate Communications
SOURCE Curaleaf Holdings, Inc.